
Access to life-changing medicines remains uneven across geographies. Our mission is to partner with patient associations, nonprofits, and advocacy groups to accelerate availability and affordability of essential therapies worldwide
We map out availability of key therapies across countries, identifying access barriers such as regulatory delays, pricing constraints, or supply gaps.
We help patient associations develop targeted advocacy strategies to bring treatments faster to patients
We facilitate collaboration between patient groups, health authorities, and industry partners to enable early access programs, compassionate use, or joint policy submissions
Our team builds data and insights to support patient-driven policy dialogues - including unmet medical needs, disease burden, and cost-benefit analyses of earlier access
From rare diseases to oncology to chronic conditions, we support patient coalitions in aligning global advocacy goals, leveraging international best practices, and amplifying patient voices in decision-making forums

Enabled patient group-led submissions to accelerate drug access timelines in emerging markets

Supported compassionate use and named-patient programs for rare disease therapies

Developed market access and affordability frameworks for advocacy coalitions in Asia, Europe, and Latin America

Partnered with global health networks to improve transparency around drug availability and reimbursement